Updates
** Shares of DNA testing firm 23andMe ME.O rise 2% to $1.50 in extended trading
** Special committee unanimously rejects CEO Anne Wojcicki's acquisition proposal
** ME's CEO Anne Wojcicki had offered to buy the remaining stake in the company for $0.41/shr, or about $11 mln
** Wojcicki said private equity firm New Mountain is no longer interested in acquiring ME
** Last month, Wojcicki and New Mountain Capital had offered to take the company private for $2.53 per share, valuing the company at $67.9 million
** As of last close, stock down 54.7% YTD
(Reporting by Padmanabhan Ananthan and Pooja Menon in Bengaluru)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.